ADIPOQ and psoriasis: In terms of treatment, anti-TNF immune-targeted therapy, such as adalimumab, and skin-directed therapy, such as ultraviolet B phototherapy, can reduce skin inflammation in patients with psoriasis, but adiponectin-induced glucose levels or insulin resistance do not change [55].